Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jan 22;16(1):e52713.
doi: 10.7759/cureus.52713. eCollection 2024 Jan.

Effect of Hyaluronic Acid-Containing Transfer Media (EmbryoGlue®) on the Live Birth Rate in Frozen Thawed Embryo Transfer Cycles

Affiliations

Effect of Hyaluronic Acid-Containing Transfer Media (EmbryoGlue®) on the Live Birth Rate in Frozen Thawed Embryo Transfer Cycles

Nihar R Bhoi et al. Cureus. .

Abstract

This retrospective cohort study examines the impact of EmbryoGlue® - a culture medium comprising high-concentration hyaluronan and low-concentration recombinant human albumin (rHA) - on assisted reproductive technology (ART) outcomes in 1,298 cycles across 13 centers. The study focused on live birth rates, clinical pregnancy, and miscarriage rates between a standard treatment arm and an EmbryoGlue® arm in frozen embryo transfer (FET) cycles. Propensity score matching ensured comparable baseline variables. Findings showed higher live birth rates (60.6% vs. 47.5%) and clinical pregnancies (69.5% vs. 57.6%) in the EmbryoGlue® group, correlating with factors like patient age and blastocyst transfer. Specifically, EmbryoGlue® showed a significant association with higher live birth rates (OR 1.593; CI 1.170-2.168; P = 0.003). These findings underscore the impact of personalized approaches and highlight EmbryoGlue®'s potential in improving successful embryo implantation, thus enhancing pregnancy rates in ART procedures. Univariate and multivariate analyses identified EmbryoGlue®, female age, and blastocyst transfer as predictors of live birth. EmbryoGlue® exhibited significance in improving clinical outcomes, mirroring previous studies' findings. Limitations in the study's design warrant further prospective research for validation. In conclusion, EmbryoGlue® appears promising for enhancing live birth rates in FET cycles, presenting a potential advancement in ART protocols.

Keywords: clinical pregnancy rate; embryoglue®; in vitro fertilization ivf; live birth rate; thawing.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Flowchart for sample selection and final study population.

Similar articles

Cited by

References

    1. Impact of Hyaluronan-enriched embryo transfer medium on the ICSI cycles outcome. Baccouri M, Debbabi L, Chtourou S, et al. 38th Hybrid Annual Meeting of the ESHRE, Milan, Italy. 2022;37:0.
    1. Hyaluronic acid in embryo transfer media for assisted reproductive technologies. Heymann D, Vidal L, Or Y, Shoham Z. Cochrane Database Syst Rev. 2020;9:0. - PMC - PubMed
    1. A randomised controlled blinded trial assessing the effectiveness of embryo glue as an embryo transfer medium in IVF cycles. Child TJ, Bevan A, Frettsome-Hook R, Craig J, Shahbazian S, Mounce G. Fertil Steril. 2021;116:4. - PubMed
    1. Effect of hyaluronic acid on development of in vitro produced bovine embryos. Furnus CC, De Matos DG, Martínez AG. Theriogenology. 1998;49:1489–1499. - PubMed
    1. Effect of embryo glue as a transfer medium in the outcome of implantation rate and live birth rate in freeze-thaw embryo transfer cycles. Tibrewal A, Rawat B, Dey P. https://pajog.com/images/pajog/issue-image/All_issue/60d5869088705202106... Pan Asian J Obs Gyn. 2021;4:14–21.

LinkOut - more resources